- Home
- CBZ vs HCM Comparison
CBZ vs HCM Comparison
Compare CBZ & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CBZ | HCM |
|---|---|---|
| Founded | 1987 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1796 |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.3B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | CBZ | HCM |
|---|---|---|
| Price | $42.14 | $11.28 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 3 | 1 |
| Target Price | ★ $41.33 | $13.75 |
| AVG Volume (30 Days) | ★ 827.4K | 46.9K |
| Earning Date | 04-29-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 134.62 | N/A |
| EPS | ★ 1.83 | N/A |
| Revenue | ★ $922,003,000.00 | N/A |
| Revenue This Year | $3.92 | $20.60 |
| Revenue Next Year | $4.12 | $15.62 |
| P/E Ratio | $23.10 | ★ $5.49 |
| Revenue Growth | ★ 7.79 | N/A |
| 52 Week Low | $24.29 | $9.77 |
| 52 Week High | $77.91 | $19.50 |
Technical Indicators
Market Signals| Indicator | CBZ | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 71.70 | 52.04 |
| Support Level | $27.84 | $9.77 |
| Resistance Level | $54.00 | $11.81 |
| Average True Range (ATR) | 1.91 | 0.29 |
| MACD | 0.71 | 0.08 |
| Stochastic Oscillator | 82.83 | 60.66 |
Price Performance
Historical ComparisonAbout CBZ CBIZ Inc.
CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.